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PATCHY SMALL BOWEL ISCHAEMIA 
SECONDARY TO SEPSIS
Editor,
Insufficient blood perfusion to the small bowel may result 
from arterial occlusion by embolus or thrombosis, thrombosis 
of the venous system, or non-occlusive processes such as 
vasospasm or low cardiac output.  Patterns of segmental, 
skipped, or patchy small bowel ischaemia have been reported 
post  abdominal  aortic  aneurysm  repair  and  is  thought  to 
imply that microembolisation has played an important role¹. 
Microvascular  thrombi  in  various  organs  can  result  from 
disseminated intravascular coagulation². We present a case 
of patchy small bowel ischaemia in a septic patient who had 
developed evidence of disseminated intravascular coagulation.
Case  presentation:  A  50-year-old  man  prescribed  four 
weeks of diclofenac for a muscular strain presented with 
frank haematemesis secondary to an eroding gastric ulcer 
measuring 7 cm in diameter. A partial gastrectomy and Roux-
en-Y  reconstruction  was  performed  and  a  massive  blood 
transfusion of 25 units was required peri-operatively.  The 
patient was referred to a tertiary care centre for intensive care 
where on day six post operatively, he developed peritonitis as 
a result of a biliary leak from his duodenal stump. His blood 
tests at that time were suggestive of non-overt disseminated 
intravascular coagulation secondary to sepsis with an elevated 
D-dimer  of  7.36  μg/ml  (0.01-0.5  μg/ml). An  emergency 
exploratory  laparotomy  was  performed.  This  revealed  a 
duodenal stump blowout and a 2 inch segment of proximal 
jejunum  containing  multiple  less  than  1  cm  blisters  in  a 
triangular arrangement (figure 1). These were found to be 
necrotic areas and were resected. Histology of the specimen 
confirmed  areas  of  transmural  haemorrhagic  ischaemic 
necrosis  associated  with  a  marked  serosal  exudate  and 
incipient perforation. Thrombi were histologically identified 
within the omentum. Later in the post-operative period he 
developed bleeding from his duodenal stump for which he had 
successful radio-embolisation of the gastroduodenal artery. 
After a complicated postoperative period, he was discharged 
home. Although, patchy bowel ischaemia has been reported 
in past, this pattern in a mid jejunal small bowel segment 
containing multiple less than 1 cm areas of necrosis in a septic 
patient has not been reported to our knowledge.
Discussion:  Patchy  small  bowel  ischaemia  has  been 
noted  in  patients  following  abdominal  aortic  aneurysm 
repair¹.  Some  of  these  patients  have  been  found  to  have 
widespread  microembolisation  or  to  have  pathological 
evidence of microemboli.  As a result it has been postulated 
that  this  pattern  of  ischaemia  is  a  direct  consequence  of 
microembolisation3.  Sepsis  almost  invariably  leads  to 
haemostatic abnormalities.  These range from the insignificant 
to severe disseminated intravascular coagulation.  Compelling 
evidence  from  clinical  and  experimental  studies  suggests 
that disseminated intravascular coagulation is involved in the 
pathogenesis of microvascular dysfunction and that deposition 
of  microvascular  thrombi  can  occur3,4.    Given  the  above 
patient had an elevated D-dimer and evidence of thrombi on 
histology it is our feeling that the likely mechanism behind 
this unusual intra-operative finding was microembolisation. 
With sepsis related disseminated intravascular coagulation 
being the most likely cause.
Conclusions: We conclude that in septic patients, the bowel 
should be carefully examined as missing such pathology will 
have serious implications for critically ill surgical patients.
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CLINICAL EXPERIENCE WITH INTRAVENOUS 
IMMUNOGLOBULIN AND TNF-Α INHIBITOR 
THERAPIES FOR RECURRENT PREGNANCY LOSS
Editor,
We report on a 22 year-old non-smoking nulligravida who 
presented with her husband for in vitro fertilisation (IVF). She 
was in good general health and had five prior unsuccessful 
IVF treatments, all with implantation failure. While her TSH 
and T4 were normal, a strongly positive (1:25,600) thyroid 
peroxidase antibody (ATA) titre was noted. Their sixth IVF 
cycle included IVIG infusion x3 as had been used in the 
immediately preceding cycle. However, etanercept (Enbrel®;  Fig 1. Proximal jejunum with multiple necrotic areas© The Ulster Medical Society, 2009.
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Immunex Corp., Thousand Oaks, California USA) was added 
for the first time as a series of 25mg subcutaneous injections 
commencing  four  weeks  before  ovulation  induction  and 
continued on four-day intervals thereafter. Eight etanercept 
injections were given until commencement of gonadotropins, 
and then discontinued. Two blastocysts were transferred fresh 
and two were frozen at day five. Following an unremarkable 
obstetrical  course,  the  patient  delivered  male/male  twins 
by Caesarean at 34½ weeks’ gestation. While the strongly 
positive ATA  titre  finding  in  our  patient  was  concerning, 
we  admitted  that  the  mechanism  of  how  ATA  impacts 
reproductive outcome is presently unknown. ATA have been 
documented more often in women with recurrent pregnancy 
failure  than  controls,  and  a  prospective  clinical  trial  of 
women  with  “immunologic  abortion”  evaluating  multiple 
autoimmune variables found ATA to be the most frequently 
encountered immunopathology—present in 53% of patients1. 
Our case, believed to be the first published report of its kind 
in Ireland, is parallel with those who have described a highly-
circumscribed use of immunomodulators for refractory cases 
where an immune diathesis exists2,3 and given only under 
closely  monitored  conditions.  While  immunomodulators 
are  inappropriate  in  IVF  for  unselected  populations  and 
should not be regarded as first-line therapy, dampening of 
immune responses antagonistic to implantation and embryo 
development  may  be  a  derivative  of  IVIG  +  etanercept 
therapy.  Should  our  patient  decide  to  enlarge  her  family 
and return for transfer of cryopreserved embryos in future, 
the role of further immunomodulator treatment will require 
consideration.
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